FLSM
ASMB icon

Frazier Life Sciences Management’s Assembly Biosciences ASMB Stock Holding History

Frazier Life Sciences Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-456,249
Closed -$11.7M – 43
2025
Q3 		$11.7M Buy
+456,249
New +$10M 0.35% 38

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Frazier Life Sciences Management's ASMB Position: Q4 2025 in Review

Frazier Life Sciences Management sold out of Assembly Biosciences (ASMB) in Q4 2025, closing a stake of 456,249 shares — an estimated $11.7M sold.

Frazier Life Sciences Management first reported a position in ASMB in Q3 2025 and held it in 1 quarter. The position peaked at $11.7M in Q3 2025. 69 funds tracked by Wall St. Rank hold ASMB as of Q4 2025.

  • Frazier Life Sciences Management reported no remaining Assembly Biosciences position as of Q4 2025 after selling out during the quarter.
  • Frazier Life Sciences Management sold 456,249 Assembly Biosciences shares in Q4 2025, an estimated $11.7M.
  • Frazier Life Sciences Management first reported a position in Assembly Biosciences in Q3 2025 and held it in 1 quarter.
  • Frazier Life Sciences Management's Assembly Biosciences position peaked at $11.7M in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2025.

Based on Frazier Life Sciences Management's 13F filing for Q4 2025, filed 13 Feb 2026.